24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Debiopharm
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:52
Weizmann Institute appeals for public support after devastating Iranian missile strike
16:05
Full list of Israeli startup M&As in 2025
16:00
Cyber unicorn Cyera acquires Otterize for tens of millions to tackle cloud identity sprawl
14:37
Hanaco Ventures winds down fundraising as founders chart new investment paths
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli military says dozens of Iranian drones foiled by electronic warfare unit
2
Cyber unicorn Cyera acquires Otterize for tens of millions to tackle cloud identity sprawl
3
Melio founders pocket over $150M each in sale to Xero
4
New Zealand's Xero acquires Melio for up to $3 billion, marking one of Israel’s largest tech exits
5
Vibe coding fever: Solo entrepreneur’s Base44 acquired by Wix for $80 million
More news
Debiopharm
1 stories about Debiopharm
AI cancer treatment startup Nucleai raises $6.5 million in series A round
07.07.20
|
Meir Orbach
Nucleai’s software uses computer vision and machine learning algorithms to predict the progress of cancerous tumors as well as the patient’s immune system response in order to determine the most efficient treatment